Brief: NeuroSense Advances Plans For Early Commercialization Of Groundbreaking ALS Treatment In Canada, Provides Further Updates

Neurosense Therapeutics

15/10/2024 14:19

Oct 15 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE ADVANCES PLANS FOR EARLY COMMERCIALIZATION OF
GROUNDBREAKING ALS TREATMENT IN CANADA, PROVIDES FURTHER UPDATES
    * NEUROSENSE THERAPEUTICS LTD: DOSSIER SUBMISSION PLANNED
FOR Q2
2025; REGULATORY DECISION EXPECTED BY Q1 2026

Source text for Eikon:  ID:nPn3CzwfLa 
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))